author-photo

Keisuke Aoe

Okayama University

190

Papers

3911

Citations

Citation Trend

Filter By

Papers (141) Sort By

Journal Conference Others

Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.

2021 Japanese Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (2)
Capmatinib in Japanese patients with MET exon 14 skipping-mutated or MET-amplified advanced NSCLC: GEOMETRY mono-1 study.

2021 Cancer Science
Show All
- Source
- Cite
- Save
Citations (1)
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study):

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PD1-1-5 Frequency of immune-related adverse events of immune-checkpoint inhibitors for non-small cell lung cancer in our single institution

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase II study of YS110, a recombinant humanized anti-CD26 monoclonal antibody, in Japanese patients with advanced malignant pleural mesothelioma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Malignant pleural mesothelioma with heterologous elements.

2021 Journal of Clinical Pathology
Show All
- Source
- Cite
- Save
Citations (0)
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR).

2020
Show All
- Source
- Cite
- Save
Citations (2)
Clinical efficacy and safety of nivolumab in Japanese patients with malignant pleural mesothelioma: 3-year results of the MERIT study

2020
Show All
- Source
- Cite
- Save
Citations (1)
Nivolumab for the treatment of unresectable pleural mesothelioma.

2020 Expert Opinion on Biological Therapy
Show All
- Source
- Cite
- Save
Citations (7)